<DOC>
	<DOCNO>NCT01923077</DOCNO>
	<brief_summary>Objective : Statins show beneficial pleiotropic effect besides lipid lowering . The investigator hypothesize early intensive statin treatment associate improved leave ventricular ( LV ) function stabilization coronary atherosclerotic plaque patient acute myocardial infarction ( AMI ) Method : In prospective randomize blind endpoint trial patient ST segment elevation non ST segment elevation AMI randomize either intensive statin-therapy ( load dose rosuvastatin 80 mg immediately randomization follow 40 mg daily ) usual statin therapy ( simvastatin 40 mg daily ) . Patients follow 12 month investigator perform echocardiography randomization , 30 day 12 month . The investigator use 2D Speckle Tracking assessment LV-function . Coronary plaque assessment do Cardiac-CT ( MSCT ) baseline 12 month . Primary outcome study assessment LV function global regional myocardial strain . Secondary outcome divide 4 group : 1 . Additional echocardiographic measurement Ejection Fraction , S´ , LV-volume , atrial volume , VA-coupling , diastolic function , post systolic strain strain rate . 2 . Biochemical assessment inflammation endothelial function : Hs-CRP , ICAM , VCAM , E-selection Nitrate/Nitrite ratio . 3 . Coronary plaque assessment MSCT : Plaque volume plaque stability . 4 . Long term follow-up : Mortality cardiovascular event</brief_summary>
	<brief_title>Intensive Statin Therapy Patients With AMI</brief_title>
	<detailed_description>Introduction Coronary heart disease ( CHD ) remain leading cause mortality western world . In Europe , CHD account one fifth death annually . Acute myocardial infarction ( AMI ) cause primarily plaque rupture demonstrate pathogenesis AMI involve interplay endothelium , inflammatory cell thrombogenicity blood . Following acute myocardial infarction ( AMI ) , profound structural change encounter , result leave ventricular ( LV ) remodel development depress cardiac function . Heart failure ( HF ) significant cause morbidity mortality worldwide estimate prevalence 1 % 2 % western world AMI remain predominant cause . Statins first develop improve lipid profile reduce development CVD . Several large randomize controlled trial show statin therapy beneficial primary secondary prevention atherothrombosis . Results two large , acute coronary syndrome trial suggest clinical benefit statin addition lipid lower effect . This stem observation cardiovascular event-rate reduction patient AMI week initiation statin treatment . Several experimental study demonstrate statin , apart LDL lower effect , exert beneficial pleiotropic effect inflammation , endothelial function , thrombosis , plaque stability ischaemic-reperfusion injury.Other experimental study animal report beneficial effect statins LV function AMI . In clinical setting statins show prevent periprocedural myocardial damage patient treat percutaneous coronary intervention ( PCI ) ARMYDA-ACS trial demonstrate protective effect statin load myocardium PCI patient ACS . Only clinical study directly investigate acute effect statins LV function patient AMI result inconclusive . All previous study concentrate patient STEMI disregard NSTEMI ; moreover , study investigate effect early statin load dose patient AMI . The investigator hypothesize early intensive statin treatment associate improved leave ventricular ( LV ) function stabilization coronary atherosclerotic plaque patient acute myocardial infarction ( AMI ) Thus , primary aim Intensify trial examine effect early intensive statin treatment LV function strain echocardiography patient AMI 30 day . Methods Study population This study prospective randomize control ( RCT ) trial blind endpoint design . The trial approve Regional Scientific Ethics Committee Southern Denmark Danish Data Protection Agency . Patients AMI define current guideline consecutively collect single coronary care unit April 2010-august 2012 . Inclusion criteria patient NSTEMI STEMI , exclusion criterion prior intensive statin treatment , contraindication intensive statin therapy time limit 24 hour hospital admission . Patients randomize either intensive statin treatment rosuvastatin 40 mg usual care simvastatin 40 mg . The intensive care group give load dose rosuvastatin 80 mg soon possible follow 40 mg daily . The usual care group treat simvastatin 40 mg daily . Apart different statin treatment , patient treat accord current national guideline . Patients follow 12 month examine immediately randomization , 1 month 12 month . Coronary angiography Culprit vessel Culprit vessel infarct location identify coronary angiography . In patient single vessel disease ( lumen stenosis &lt; 50 % ) diseased vessel identify culprit . In patient multi-vessel disease , culprit vessel identify combination angiographic electrocardiographic criterion . In patient normal CAG use electrocardiographic multi-slice computer tomography identify culprit lesion . If culprit lesion could find , patient exclude study . The investigator use AHA scientific statement myocardial segmentation nomenclature tomographic image 2002 define coronary artery supply area myocardium . Echocardiography Echocardiography perform randomization 30 day use GE Vivid 7 ultrasound system ( GE Medical System Inc. , Horten , Norway ) standard 3.5 MHz ultrasound probe . A standardized protocol follow examination examination perform one operator . Consecutive heartbeat record sweep speed 25 mm/s digitally store , blind patient identity . Examinations analyze off-line one experience observer use EchoPAC version 1.12.0 ( GE , Vingmed ) . All analysis do sweep speed 67 mm/s recording measure average 3 consecutive heartbeat . Examinations poor image quality patient atrial fibrillation exclude analysis . Left ventricular- atrial volume estimate use Simpsons biplane method discs 4- 2 chamber view ejection fraction calculate . Mitral inflow pattern estimate apical four chamber view pattern peak early ( E ) peak atrial ( A ) velocity measure . E/A ratio calculate divide E A. Mitral annular velocity estimate apical 4- 2 chamber view use pulse wave tissue Doppler imaging . A pulsed wave Doppler sample volume place level mitral annulus first lateral wall , septum finally anterior- posterior wall . Using tissue Doppler imaging peak early ( E´ ) , peak systolic ( S´ ) mitral annular velocity estimate . E/E´ ratio obtain divide E E´ . Strain analyse Longitudinal systolic strain measure speckle track echocardiography . This obtain 2D gray scale image apical 4-chamber , 2-chamber long-axis view optimize focus leave ventricle frame rate ≥ 69 frames/sec . Duration systole define 5-chamber apical view mark aorta valve open closure continuous wave Doppler curve . Strain analyse do EchoPAC version 1.12.0 ( GE , Vingmed ) Q-analysis software . The left ventricular borderline manually trace apical plane track motion automatically do software . Peak systolic strain determine 18 segment three apical view . Global strain leave ventricle provide software average value peak systolic longitudinal strain three apical view . Strain infarct zone calculate mean value segment supply culprit vessel Time intensive statin bolus : Patients randomize intensive care group give load bolus rosuvastatin 80 mg soon possible admission continue intensive treatment 40 mg daily . Patients randomize usual care group treat current guideline simvastatin 40 mg daily start statin therapy discharge hospital . Patients treat intensively divide two group . A early statin group receive statin treatment 12 hour admission early statin group receive statin 12 hour 24 hour admission hospital . MSCT : The investigator perform contrast enhanced Cardiac CT ( MSCT ) randomization 12 month . The investigator use standardize protocol every examination detail method description see elsewhere . Biochemistry : Blood drawn baseline randomization 30 day . The investigator measure lipid-profile HBA1C , Creatinin , ALAT CK . Statistical analysis Continuous outcome variable present mean ± standard deviation ( SD ) . Changes outcome variable baseline follow-up present Delta ( ∆ ) value ( follow-up value - baseline value ) Differences group analyze unpaired Students t-test unequal variance . The investigator use multiple linear regression order adjust potential confounders . The investigator define confounders : Baseline leave ventricular output variable , diabetes , hypertension , hypercholesterolemia , prior statin treatment , history ACS , type infarction , type invasive treatment , culprit vessel , beta-blockers , ACE/ARB-inhibitors time symptom invasive treatment . Continuous exposure variable present median low upper quartile categorical data frequency percentage . Difference exposure variable test Krushal-Wallis test continuous variable categorical variable Fischer 's exact test . Statistical test two-sided , P-value &lt; 0.05 consider statistically significant . All statistical analysis perform use STATA version 12 ( StataCorp LP , Collage Station , TX , USA )</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>All patient NSTEMI STEMI prior intensive statin treatment contraindication intensive statin therapy Time limit 24 hour hospital admission .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>acute myocardial infarction</keyword>
	<keyword>Statin</keyword>
	<keyword>speckle track echocardiography</keyword>
	<keyword>Strain</keyword>
	<keyword>MSCT</keyword>
	<keyword>plaque</keyword>
	<keyword>vulnerable plaque</keyword>
</DOC>